Miguel Montalvo
Instructor Miguel Montalvo
Product Id 600616
Duration 60 Minutes  
Version Recorded
Original Price $295
Special Offer Price $10
Refund Policy
Access recorded version only for one participant; unlimited viewing for 6 months

Change Control Management – From Design to Commercialization

Overview:

There is a need to implement an adequate formal level of change control during engineering projects (referred to as an Engineering Change Control) after the approval of the equipment/systems specifications in addition to the more formal change control after the qualification of these systems.

The Engineering change control process will apply through design, construction and qualification up to the point that the system is considered installed/operational. The new Quality Systems guideline from the FDA states that the Quality function must be involved in the review of the design and subsequent changes to the design of facilities, equipment and systems that may impact the product quality. The question is - how much involvement is really necessary from all functional groups including the Quality group?

The course will include instructions on how to:

  • Develop an Engineering Change Control system for design, construction projects and the elements of a formal Change Control system after commercialization
  • Apply change control concepts while making it a practical but effective process
  • Determine which equipment/systems require some level of change control after the approval of specifications and which systems do not require a formal level of change control during these stages of a project
  • Understand the documentation requirements, approvals and responsible resource for conducting change control at these phases and after commercialization

Why you should attend: Most pharmaceutical companies focuses on change control management after commercialization but changes must be managed earlier during the design of facilities, equipment and systems in addition to changes implemented during the development of the manufacturing processes. The question is: What is the level of control required at the design/development stages? Who needs to be involved? What are the steps required for the processing of such changes and the documentation that is required to provide evidence of such controls?

Areas Covered in the Session:
  • Specifications Change Control
    • Handling of changes to URS, FRS, Design Specifications
    • When do we implement some level of Change control
  • Design Change Control
    • Relationship between Design Qualification/Review and Change Control
    • Adequate/Practical Documentation Requirements for changes during design – handling of drawings
    • Functions to be involved and level of involvement
  • Change Control during Construction, Start-Up and Commissioning
    • Handling of Revisions to Design, Drawings and Specifications
    • Changes to Construction Reports/Documentation
    • Change Control Management during Qualification
  • Formal Change Control Management after Equipment/Systems Qualification
    • Standards/Regulations/Guidelines applicable to Change Control and Training Requirements
    • Learn the characteristics of an adequate/effective procedure and documentation form and how to deliver this message during training:
      • Definitions – Like for Like, Emergency/Unplanned vs. Normal/Planned Changes
      • Applications for Documentation Changes
      • Applications for Process Changes
      • Applications for Changes in equipment/systems

Who Will Benefit:
  • Personnel in Manufacturing
  • Engineering
  • Quality
  • Validations
  • Purchasing at all levels of management

Speaker Profile
Miguel Montalvo, B.S. Chem. Eng., MBA, President, Expert Validation Consulting, has over twenty-eight years of professional/management experience in positions of increasing responsibility in the areas of Quality, Validations and Technical Services within the traditional pharmaceutical, OTC Drugs, cosmetics, dietary supplements, biotechnology and medical device industries including extensive expertise on development and implementation of quality functional procedures (QA/QC), Quality Systems, GMP/QSR compliance audits (internal, supplier, external audits), remediation projects with companies on consent decrees, handling of non-conformances (OOS, investigations and deviations), Process/Cleaning/Computer Systems/Equipment/Facility validations, Change Control, CAPA, international GMP compliance, Calibrations, Risk Management, operational compliance assessments/Gap Analysis and start-up of manufacturing facilities.

He is a well-recognized international speaker on GMP Compliance, Validation and Quality related topics for organizations such as IVT, PDA-TRI, CfPIE and Barnett International and his articles/papers have been published in the American Pharmaceutical Review and the Journal of Validation Technology publications and have been published as an author of specific chapters in several design/quality/validation related internationally-recognized reference books. He is a member of the Journal of Validation Technology editorial board and of the PDA Annual Program Committee for their Annual meetings.

Sign Up for Our Newsletter